Background
Atopic dermatitis (AD) may affect cognitive function, but studies are limited and inconsistent. The effect of AD severity on cognition remains underexplored and few previous studies have examined clinically validated or repeated measures of cognition throughout childhood.
Objective
To evaluate the relationship of AD activity and severity with validated measures of general cognition in a longitudinal birth cohort.
Methods
We conducted cross-sectional analyses using data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a U.K. cohort of 14,975 individuals followed prospectively since their birth in 1991-1992. AD was assessed 11 times between 6 and 166 months old. Mothers were asked if their child had an “itchy, dry skin rash in the joints and creases,” and AD status was accordingly time-updated as never, maybe, inactive, active/mild, or active/moderate-severe. General cognition (i.e., IQ) was measured at 18, 49, 103, and 186 months old using the Griffiths Mental Development Scales (GMDS), Wechsler Preschool and Primary Scale of Intelligence (WPPSI), Wechsler Intelligence Scale for Children (WISC), and Wechsler Abbreviated Scale of Intelligence (WASI), respectively. Multivariable linear regression was used to compare IQ with respect to nearest time-updated AD status. Secondary analyses were stratified by the presence or absence of psychiatric or learning disorders. An exploratory longitudinal analysis of IQ across all four outcome assessments was conducted using generalized estimating equations.
Results
No significant associations between AD status and full-scale IQ scores on the GMDS, WPPSI, WISC, and WASI were observed after adjustment for sociodemographic factors, atopic comorbidities, and sleep characteristics. However, at 8 years old, WISC Performance IQ was slightly though statistically significantly lower among children with active/moderate-severe AD (β-coefficient -2.16 [95% CI -4.12, -0.19]) and Verbal IQ was slightly but statistically significantly higher among those with inactive AD (β 1.31 [0.28, 2.34]) compared to those without AD. Analyses stratified by psychiatric or learning disorders, and exploratory longitudinal analyses of cognition revealed similar findings.
Conclusions
We did not find any clinically meaningful associations between AD activity and severity and general cognitive function during early childhood and adolescence. Future studies should incorporate objective measures of AD severity and investigate outcomes beyond IQ.